Profil
Russell Smith is the founder of Avidex Ltd.
which was founded in 1998.
He is a former Chief Executive Officer of Prolysis Ltd., former Chairman of Surface Therapeutics Ltd., former Non-Executive Director of Glide Pharmaceutical Technologies Ltd., and former Principal of Business Boffins Ltd.
Anciens postes connus de Russell Smith
| Sociétés | Poste | Fin |
|---|---|---|
Avidex Ltd.
 Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | Fondateur | 04/12/2008 |
Surface Therapeutics Ltd.
 Surface Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Surface Therapeutics Ltd. develops novel drugs & diagnostics for asthma and epithelial diseases. It also develops new pharmaceutical products for the treatment of inflammatory epithelial diseases with a focus on the skin and lungs. The company was founded in 2004 and is headquartered in Abingdon, LO. | Président | - |
Business Boffins Ltd.
 Business Boffins Ltd. Miscellaneous Commercial ServicesCommercial Services Business Boffins Ltd. provided education management services. The company was headquartered in Chinnor, the United Kingdom. | Corporate Officer/Principal | - |
Prolysis Ltd.
 Prolysis Ltd. Pharmaceuticals: MajorHealth Technology Prolysis Ltd. develops and manufactures pharmaceutical products. It develops antibacterial therapy to treat drug resistant infections. The company was founded in 1998 and is headquartered in Kidlington, UK. | President | - |
Glide Pharmaceutical Technologies Ltd.
 Glide Pharmaceutical Technologies Ltd. Pharmaceuticals: MajorHealth Technology Glide Pharmaceutical Technologies Ltd. developed and manufactured pharmaceutical products. The firm developed SDI, a solid dose injector system to improve compliance in patients self-administering long term therapy. Its pipeline of solid dose formulations includes octreotide, teriparatide, and anthrax and influenza vaccines. It also engaged in developing a non-invasive diagnostic technology that primarily focuses on prostate cancer, which aims to identify clinically significant disease based on a biochemical marker. The company was founded by Charles David Ogilvy Potter on 6th March, 2001 and was headquartered in Abingdon, the United Kingdom. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Avidex Ltd.
Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | Health Technology |
Prolysis Ltd.
Prolysis Ltd. Pharmaceuticals: MajorHealth Technology Prolysis Ltd. develops and manufactures pharmaceutical products. It develops antibacterial therapy to treat drug resistant infections. The company was founded in 1998 and is headquartered in Kidlington, UK. | Health Technology |
Glide Pharmaceutical Technologies Ltd.
Glide Pharmaceutical Technologies Ltd. Pharmaceuticals: MajorHealth Technology Glide Pharmaceutical Technologies Ltd. developed and manufactured pharmaceutical products. The firm developed SDI, a solid dose injector system to improve compliance in patients self-administering long term therapy. Its pipeline of solid dose formulations includes octreotide, teriparatide, and anthrax and influenza vaccines. It also engaged in developing a non-invasive diagnostic technology that primarily focuses on prostate cancer, which aims to identify clinically significant disease based on a biochemical marker. The company was founded by Charles David Ogilvy Potter on 6th March, 2001 and was headquartered in Abingdon, the United Kingdom. | Health Technology |
Surface Therapeutics Ltd.
Surface Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Surface Therapeutics Ltd. develops novel drugs & diagnostics for asthma and epithelial diseases. It also develops new pharmaceutical products for the treatment of inflammatory epithelial diseases with a focus on the skin and lungs. The company was founded in 2004 and is headquartered in Abingdon, LO. | Health Technology |
Business Boffins Ltd.
Business Boffins Ltd. Miscellaneous Commercial ServicesCommercial Services Business Boffins Ltd. provided education management services. The company was headquartered in Chinnor, the United Kingdom. | Commercial Services |
